Clostridium difficile: un entéropathogène majeur en milieu hospitalier

[1]  J. Brazier.  The laboratory diagnosis of Clostridium difficile‐associated disease , 1995 .

[2]  P. Bourbeau,et al.  Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients: role of sucralfate. , 1994, The Journal of infectious diseases.

[3]  Y. Hutin,et al.  Risk factors for Clostridium difficile‐associated diarrhoea in HIV‐infected patients , 1993, AIDS.

[4]  F. Knoop,et al.  Clostridium difficile: clinical disease and diagnosis , 1993, Clinical Microbiology Reviews.

[5]  M. Delmée,et al.  Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients , 1993, Journal of clinical microbiology.

[6]  Mark A. Miller,et al.  Risk Factors for the Development of Clostridium difficile-Associated Diarrhea During a Hospital Outbreak , 1991, Infection Control & Hospital Epidemiology.

[7]  C. Surawicz,et al.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. , 1990, The Journal of infectious diseases.

[8]  G. Talbot,et al.  Risk factors for Clostridium difficile toxin-associated diarrhea. , 1990, Infection control and hospital epidemiology.

[9]  M. Tvede,et al.  Incidence of Clostridium difficile in Hospitalized Children A Prospective Study , 1990, Acta paediatrica Scandinavica.

[10]  M. Cerf,et al.  Diarrhée des antibiotiques , 1990 .

[11]  C. Quentin,et al.  Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates. , 1989, Annales de biologie clinique.

[12]  T. Wilkins,et al.  Clostridium difficile: its disease and toxins , 1988, Clinical Microbiology Reviews.